Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. [electronic resource]
Producer: 20070727Description: 1550-1 p. digitalISSN:- 0091-6749
- Adolescent
- Anaphylaxis -- drug therapy
- Anti-Allergic Agents -- therapeutic use
- Antibodies, Anti-Idiotypic
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Humans
- Male
- Mastocytosis, Systemic -- drug therapy
- Middle Aged
- Omalizumab
- Receptors, IgE -- antagonists & inhibitors
- Urticaria Pigmentosa -- drug therapy
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.